The Food and Drug Administration has approved Piqray (alpelisib) tablets to treat men and postmenopausal women whose advanced breast cancer is hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative and PIK3CA-mutated.
Piqray is to be used in combination with the FDA-approved endocrine therapy fulvestrant. The PIK3CA-mutated, advanced or metastatic breast cancer (as detected by an FDA-approved test) is indicated following progression on or after an endocrine-based regimen.
Continue reading “FDA approves new drug to treat advanced breast cancer”
Broccoli and other cruciferous vegetables (such as arugula, Brussels sprouts, cabbage, collard greens, cauliflower, and kale) “contain a molecule that inactivates a gene known to play a role in a variety of common human cancers” although you can’t eat your way to cancer suppression.
Scientists at Harvard Medical School’s Beth Israel Deaconess Medical Center discovered that an enzyme which plays a role in many cancers “can be inhibited with a natural compound found in broccoli and other cruciferous vegetables.” Their research is preliminary, focused on prostate cancer prone mice and human cells.
Continue reading “Yes, Virginia, you should eat your broccoli”
On a cold, bright Sunday afternoon during New York Fashion Week, nearly six hundred people packed into an old building in Manhattan’s Lower East Side for an unusual lingerie show.
It was the third annual #Cancerland fashion show sponsored by the lingerie company AnaOno and METAvivor, a nonprofit organization advocating for metastatic breast cancer (MBC) research and awareness.
Continue reading “Reframing metastatic breast cancer”
Doctors should resample patient tissue should cancer spread, rather than relying on the initial biopsy, according to research focused on estrogen-positive breast cancer.
Continue reading “New biopsy recommended when breast cancer spreads”